| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.22 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |